Trade groups irked with FDA following CBD report to Congress
Supplement RegulationsTrade groups irked with FDA following CBD report to CongressTrade groups irked with FDA following CBD report to Congress
FDA’s 15-page report to the House and Senate appropriations committees was met with criticism from some leaders in the natural products and hemp industries, who have said the agency is dragging its heels on actively regulating a hemp-derived compound that has proliferated in U.S. products marketed as dietary supplements.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.